Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Recombinant Insulin Lispro Injection Supply, Demand and Key Producers, 2024-2030

date 11 Feb 2024

date Medical Devices & Consumables

new_biaoQian Recombinant Insulin Lispro Injection

The global Recombinant Insulin Lispro Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Insulin Lispro Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 07 Jan 2024

date Medical Devices & Consumables

new_biaoQian Recombinant Insulin Lispro Injection

According to our (Global Info Research) latest study, the global Recombinant Insulin Lispro Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Insulin Lispro Injection Supply, Demand and Key Producers, 2023-2029

date 14 Feb 2023

date Medical Devices & Consumables

new_biaoQian Recombinant Insulin Lispro Injection

The global Recombinant Insulin Lispro Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Insulin Lispro Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 13 Jan 2023

date Medical Devices & Consumables

new_biaoQian Recombinant Insulin Lispro Injection

The main component of recombinant insulin lispro injection is insulin lispro, which is a human insulin analog produced by genetic recombination technology. It is produced by exchanging the 28th and 29th amino acids on the insulin B chain. It is suitable for the need for insulin Adult diabetic patients who maintain euglycemic homeostasis

USD3480.00

Add To Cart

Add To Cart

industry 11 Feb 2024

industry Medical Devices & Consumables

new_biaoQian Recombinant Insulin Lispro Injection

The global Recombinant Insulin Lispro Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 07 Jan 2024

industry Medical Devices & Consumables

new_biaoQian Recombinant Insulin Lispro Injection

According to our (Global Info Research) latest study, the global Recombinant Insulin Lispro Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 14 Feb 2023

industry Medical Devices & Consumables

new_biaoQian Recombinant Insulin Lispro Injection

The global Recombinant Insulin Lispro Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 13 Jan 2023

industry Medical Devices & Consumables

new_biaoQian Recombinant Insulin Lispro Injection

The main component of recombinant insulin lispro injection is insulin lispro, which is a human insulin analog produced by genetic recombination technology. It is produced by exchanging the 28th and 29th amino acids on the insulin B chain. It is suitable for the need for insulin Adult diabetic patients who maintain euglycemic homeostasis

USD3480.00

addToCart

Add To Cart